Sequence information
DRAVP ID DRAVPc010
Name Golotimod
Sequence
Molecular Formula C16H19N3O5
Condition/Disease Chronic HCV infection
Group Phase â…¡clinical trial
Type Peptide
Description Golotimod(SCV-07) is a novel synthetic dipeptide containing the amino acids D-glutamine and L-tryptophan, which is used to treat hepatitis C by oral administration. SCV-07 has shown efficacy in treating various viral and bacterial infections.
Active sequence/Structure
External Links
DrugBank Accession Number DB05475
Pubchem ID 6992140
CHEMBL ID CHEMBL2103812
UNII 637C487Y09
CAS 229305-39-9
Reference 34258744
ClinicalTrails Information
| NCT Number | Study Title | Condition/Disease | Status | Phase | Sponsor |
|---|---|---|---|---|---|
| NCT00968357 | Proof-of-concept Study to Evaluate the Safety and Immunomodulatory Effects of SCV 07 as Monotherapy or in Combination With Ribavirin in Noncirrhotic Subjects With Chronic Hepatitis C Who Have Relapsed | Chronic Hepatitis C virus infection | Completed | Phase 2 | SciClone Pharmaceuticals |
